We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01376154
First Posted: June 20, 2011
Last Update Posted: May 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
GlaxoSmithKline
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)

To Top